4//SEC Filing
5AM VENTURES LLC 4
Accession 0001181431-13-006519
CIK 0001293310other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 7:11 PM ET
Size
8.6 KB
Accession
0001181431-13-006519
Insider Transaction Report
Form 4
5AM Partners LLC
10% Owner
Transactions
- Purchase
Common Stock
2013-01-31$8.00/sh+62,500$500,000→ 223,190 total
5AM CO INVESTORS LLC
10% Owner
Transactions
- Purchase
Common Stock
2013-01-31$8.00/sh+62,500$500,000→ 223,190 total
5AM VENTURES LLC
10% Owner
Transactions
- Purchase
Common Stock
2013-01-31$8.00/sh+62,500$500,000→ 223,190 total
Footnotes (3)
- [F1]The shares were acquired as follows: 54,745 shares by 5AM Ventures LLC ("Ventures") and 7,755 shares by 5AM Co-Investors LLC ("Co-Investors").
- [F2]Reflects 1-for-3.56147 reverse stock split which became effective on January 15, 2013.
- [F3]The shares are held as follows: 195,349 shares Ventures and 27,841 shares by Co-Investors. 5AM Partners LLC is the general partner of Ventures and Co-Investors. The managing directors of 5AM Partners LLC are Dr. John D. Diekman and Andrew J. Schwab.
Documents
Issuer
KALOBIOS PHARMACEUTICALS INC
CIK 0001293310
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001178419
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 7:11 PM ET
- Size
- 8.6 KB